My Digital Badge

First Name:
Last Name:
Clinical Speciality:
Select your country

What is your first name?

What is your last name?

What is your clinical speciality?

Regulatory device registrations for the products described in this website are not completed in your country. The products can therefore not be promoted and are not yet available for sale.
Your request for future access is saved!
Your badge is complete!
By clicking ENTER, I agree to GE Healthcare storing my details and contacting me concerning my interests (read more)


  1. Budoff M, Young R, Burke G, et al. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA). European Heart Journal (2018) 39, 2401–2408
  2. Applicable to AI View Recognition, results based on GE internal data (DOC2292732)
  3. Smedsrud M, Sarvari, S, Haugaa K, et al. Duration of Myocardial Early Systolic Lengthening Predicts the Presence of Significant Coronary Artery Disease.Journal of the American College of Cardiology Volume 60, Issue 12, 18 September 2012, Pages 1086- 1093
  4. Marquette 12SL Physician’s Guide 2056246-002C
  5. Knuuti J, Wijns W, Saraste A, et al.; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020 Jan 14;41(3):407-477.Erratum in: Eur Heart J. 2020 Nov21;41(44):4242. PMID: 31504439
  6. Michos ED Greenland P. Coronary Computed Tomography Angiography in Stable Chest Pain to Prevent Myocardial Infarction and Reduce Costs-Seeing is Believing. JAMA Netw Open/ 2020;3(12):e2030996
  7. SCOT-HEART investigators. CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Lancet. 2015 Jun 13;385(9985):2383-91. Epub 2015 Mar 15. Erratum in: Lancet. 2015 Jun 13;385(9985):2354. PMID: 2578823
  8. Paech DC, Weston AR. A systematic review of the clinical effectiveness of 64-slice or higher computed tomography angiography as an alternative to invasive coronary angiography in the investigation of suspected coronary artery disease. BMC Cardiovascular Disorders 2011,11:32. 
  9. Financial simulation from GE Healthcare.: CardioGraphe Cost $830k, 100% financed, 5% rate y lean, 7y depreciation, Build out $25k, service cost $90k, reimbursement $398, variable cost/proc $25, patient/day 10, days/month 21. Compared to Revolution CT cost $1,600k.
  10. Compared to GE Revolution CT. From Product Installation Manual.
  11. Ng A, Sitges M, Pham P, et al. Incremental value of 2-dimensional speckle tracking strain imaging to wall motion analysis for detection of coronary artery disease in patients undergoing dobutamine stress echocardiography. Am Heart J. 2009 Nov;158(5):836-44. Epub 2009 Oct 3.
  12. Qiu, S., et al., Heart Rate Recovery and Risk of Cardiovascular Events and All‐Cause Mortality: A Meta‐Analysis of Prospective Cohort Studies. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017. 6(5): p. e005505.
  13. Sydó, N., et al., Prognostic Performance of Heart Rate Recovery on an Exercise Test in a Primary Prevention Population. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018. 7(7): p. e008143. 
  14. Jahnke C, Nagel E, et al.Prognostic Value of Cardiac Magnetic Resonance Stress Tests Circulation. 2007;115:1769–1776.
  15. Leiner, T., Bogaert, J., Friedrich, M.G. et al. SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance. J Cardiovasc Magn Reson 22, 76 (2020). 
  16. Journal of the American College of Cardiology. Vol. 53, No. 23, 2009 © 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc.
  17. As compared to conventional technology
  18. Improvement vs. same test without PCI ASSIST option. IQ & visibility improvement is measured on Innova IGS530 with phantoms using various Plexiglas Thicknesses, acquisition parameters and the NEMA spoke wheel tool (ref 1), calculating the ratio of the contrast of the moving wires to the background noise level. The amount of IQ improvement related to PCI ASSIST depends on the acquisition parameters, clinical task, patient size, amount of motion in the image, anatomical location, and clinical practice. Ref1: A new tool for benchmarking cardiovascular fluoroscopes; S. Balter, Radiation Protection Dosimetry, Vol. 94, No. 1–2 pp. 161–166 (2001). Applicable to Innova IG
  19. PCI ASSIST solution includes StentViz and StentVesselViz, features of Interventional X-ray systems Innova IGS 5, Innova IGS 6, Discovery IGS 7 and Discovery IGS 7 ORS
  20. Nagueh S, Smiseth O, Appleton C, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2016;29:277-314
  21. Daly C, De Stavola B, Lopez Sendon J, et al. Predicting prognosis in stable angina—results from the Euro heart survey of stable angina: prospective observational study. BMJ 2006;332:262
  22. Amsterdam EA, Wenger NK, et al. AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes. J Am Coll Cardiol. 2014 Dec 23;64(24):e139-e228
  23. Haugaa K, Smedsrud M, Steen T, et al. Mechanical Dispersion Assessed by Myocardial Strain in Patients After Myocardial Infarction for Risk Prediction of Ventricular Arrhythmia. JACC: Cardiovascular Imaging Volume 3, Issue 3, March 2010, Pages 247-256 IGS 520, IGS
  24. Applicable to AI Auto Measure 2D
  25. C Daly, J Norrie, D.L Murdoch, I Ford, H.J Dargie, K Fox for the TIBET (Total Ischaemic Burden European Trial) study group. The value of routine non-invasive tests to predict clinical outcome in stable angina European Heart Journal, Volume 24, Issue 6, 1 March 2003, Pages 532–540